Oncology - European Medical Journal

Continue

Oncology

Filter
24 May 2017

Immunoscore®, Immunosign® and Halioseek™ at ASCO 2017

Marseille, France, May 23, 2017 – HalioDx SAS, an immuno-oncology diagnostic company, announced its participation at the 2017 American Society of…
16 May 2017

Philips Showcases New Integrated Image-Guided Therapy Solutions at 2017 EuroPCR to Transform Cardiac Care and Help Improve Patient Care

Amsterdam, May 16, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA) will showcase its market-leading image guided therapy solutions at EuroPCR 2017…
11 May 2017

University Research Opens Door to U.S. Market for UK Chemotherapy Scalp Cooling Firm

Huddersfield, UK, 10 May, 2017 – A pioneering UK company that produces technology designed to reduce hair loss during cancer treatment has been given…
9 May 2017

Introducing EMJ Urology 5.1

United Kingdom, May 09, 2017: Welcome to the newest edition of our EMJ Urology eJournal, packed with the latest urological developments. This issue is…
2 May 2017

New Hope in Fight Against Pancreatic Cancer

MIR506, a small microRNA molecule, could be the key to new treatments to suppress deadly and aggressive pancreatic cancer, a new study has found. Through…
26 Apr 2017

European Society for Medical Oncology (ESMO): Annual Flu Jab May Pose Greater Risk for Lung Cancer Patients Under Immunotherapy

Geneva, Switzerland, 26 April, 2017 – Lung cancer patients treated with immunotherapy may be at increased risk of adverse events after receiving the…
5 Apr 2017

RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma

Tel-Aviv, Israel, April 04, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…
5 Apr 2017

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
We’ve noticed you’re accessing
from North/South America.